Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TheraCal vs MTA-Anglus for Pulpotomy in Young Permanent Molars
NCT03119779Completed
- Sponsor
- Cairo University
- Start
- Sep 2015
- Primary completion
- Apr 2017
- Modality
- Implantable Devices
01
Overview
Randomised, double-blind trial of TheraCal in dental caries (2 arms), sponsored by Cairo University. Primary endpoint: Tooth Survival Rate at 12 months. Started Sep 2015; status: completed.
02
Drugs
TheraCal
03
Conditions
dental caries
Beyond the preview
Go deeper on NCT03119779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03119779.